Use of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention: insights from the APEX-AMI trial.
暂无分享,去创建一个
P. Armstrong | C. Granger | K. Huber | D. Holmes | G. Montalescot | P. Aylward | P. Widimsky | C. Westerhout | A. W. van ’t Hof | G. A. Betriu